HDL and atherothrombotic vascular disease (Q38293467)

1 September 2017

1 reference

title

HDL and atherothrombotic vascular disease (English)

1 reference

1 September 2017

Arnold von Eckardstein

series ordinal

2

object named as

Arnold von Eckardstein

1 reference

1 September 2017

Wijtske Annema

1

1 reference

PubMed ID

25522995

1 September 2017

Petri T Kovanen

series ordinal

3

1 reference

1 September 2017

1 January 2015

1 reference

Handbook of experimental pharmacology

1 September 2017

1 reference

1 September 2017

224

1 reference

1 September 2017

369-403

1 reference

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

1 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Effects of torcetrapib in patients at high risk for coronary events

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Atherosclerotic plaque development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

ATP-Binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

The β-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

New molecular insights into CETP structure and function: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL does not influence the polarization of human monocytes toward an alternative phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Pathogenetic concepts of acute coronary syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Oxidised LDL (OxLDL) induces production of platelet derived growth factor AA (PDGF AA) from aortic smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High density lipoproteins downregulate basic fibroblast growth factor production and release in minimally oxidated-LDL treated smooth muscle cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Major lipids, apolipoproteins, and risk of vascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Effect of Antioxidants on Oxidative Modification of LDL

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Cysteine cathepsins and extracellular matrix degradation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

ABCG1-mediated generation of extracellular cholesterol microdomains

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Intracoronary imaging for detecting vulnerable plaque

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Atherothrombosis and high-risk plaque: part I: evolving concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Development of the lipid-rich core in human atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Inflammation, atherosclerosis, and coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

An abundant dysfunctional apolipoprotein A1 in human atheroma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

The role of hypoxia in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern G

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Extracellular modifications of HDL in vivo and the emerging concept of proteolytic inactivation of preβ-HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

The role of the gut in reverse cholesterol transport--focus on the enterocyte

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

New insights into the regulation of HDL metabolism and reverse cholesterol transport

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Molecular bases of the acute coronary syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Inflammation in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Collagenases and cracks in the plaque

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Mechanisms of acute coronary syndromes and their implications for therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Endothelial functions of sphingosine-1-phosphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein reduces the human monocyte inflammatory response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Flow shear stress and atherosclerosis: a matter of site specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Stimulation of cell surface F1-ATPase activity by apolipoprotein A-I inhibits endothelial cell apoptosis and promotes proliferation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Interleukin 6 stimulates endothelial binding and transport of high-density lipoprotein through induction of endothelial lipase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Pathophysiology of atherosclerosis plaque progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Effects of dalcetrapib in patients with a recent acute coronary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Reconstituted high-density lipoprotein modulates activation of human leukocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Nonoxidative modifications of lipoproteins in atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Ultrastructure of early lipid accumulation in ApoE-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Reconstituted HDL Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Regulatory Effects of HDL on Smooth Muscle Cell Prostacyclin Release

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

A Novel Lecithin-Cholesterol Acyltransferase Antioxidant Activity Prevents the Formation of Oxidized Lipids during Lipoprotein Oxidation†

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Endothelial shear stress in the evolution of coronary atherosclerotic plaque and vascular remodelling: current understanding and remaining questions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

The response-to-retention hypothesis of early atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Immunological aspects of atherosclerosis: Figure 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through sphingosine kinase-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Importance of different pathways of cellular cholesterol efflux

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Monocyte heterogeneity in human cardiovascular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Chemokines in the vascular inflammatory response of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-09665-0_11

10.1007/978-3-319-09665-0_11

31 March 2020

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25522995